{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:48Z","timestamp":1791644688886,"version":"4.3.4"},"reference-count":136,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jaad.2021.05.016","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T07:25:24Z","timestamp":1621841124000},"page":"551-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement"],"prefix":"10.1016","volume":"86","author":[{"given":"Celina","family":"Dubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob W.","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Del Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanth","family":"Chennareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Dahabreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace W.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashkura","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Angelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Gay-Mimbrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ruano Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ced.13785","article-title":"Risk factors associated with frontal fibrosing alopecia: a multicentre case\u2013control study","volume":"44","author":"Moreno-Arrones","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.05.016_bib2","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/jdv.15735","article-title":"Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases","volume":"33","author":"Kanti","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jaad.2021.05.016_bib3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/jdv.14582","article-title":"The increasing incidence of frontal fibrosing alopecia. In search of triggering factors","volume":"31","author":"Rudnicka","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.19040","article-title":"Frontal fibrosing alopecia shows robust Th1 and JAK3 skewing","volume":"183","author":"Del Duca","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40257-019-00424-y","article-title":"Frontal fibrosing alopecia: an update on pathogenesis, diagnosis, and treatment","volume":"20","author":"Iorizzo","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaad.2020.08.076","article-title":"Risk factors for frontal fibrosing alopecia: a case-control study in a multiracial population","volume":"84","author":"Ramos","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamadermatol.2017.6330","article-title":"Health-related quality of life in patients with frontal fibrosing alopecia","volume":"154","author":"Saceda-Corralo","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0037-1615281","article-title":"Frontal fibrosing alopecia: a retrospective analysis of 72 patients from a German academic center","volume":"34","author":"Heppt","year":"2018","journal-title":"Facial Plast Surg"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5114\/ada.2020.98241","article-title":"Frontal fibrosing alopecia: a disease that remains enigmatic","volume":"37","author":"Lis-\u015awi\u0119ty","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2133.2008.08861.x","article-title":"Frontal fibrosing alopecia: clinical presentations and prognosis","volume":"160","author":"Tan","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijwd.2018.11.003","article-title":"Frontal fibrosing alopecia: an update on the hypothesis of pathogenesis and treatment","volume":"5","author":"Tavakolpour","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1203475417736279","article-title":"Frontal fibrosing alopecia: update and review of challenges and successes","volume":"22","author":"To","year":"2018","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ajd.12945","article-title":"An update of the pathogenesis of frontal fibrosing alopecia: what does the current evidence tell us?","volume":"60","author":"Photiou","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.05.016_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/cup.12955","article-title":"Inflammatory features of frontal fibrosing alopecia","volume":"44","author":"Ma","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2021.05.016_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IJWH.S177308","article-title":"Frontal fibrosing alopecia: efficacy of treatment modalities","volume":"11","author":"Gamret","year":"2019","journal-title":"Int J Womens Health"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5582\/irdr.2016.01065","article-title":"Frontal fibrosing alopecia treatment options","volume":"5","author":"Fertig","year":"2016","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/ijt.ijt_46_18","article-title":"A retrospective analysis of efficacy and safety of intralesional triamcinolone injections in the treatment of frontal fibrosing alopecia either as monotherapy or as a concomitant therapy","volume":"10","author":"Gkini","year":"2018","journal-title":"Int J Trichology"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2013.12.003","article-title":"Frontal fibrosing alopecia: a multicenter review of 355 patients","volume":"70","author":"Vano-Galvan","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.05.016_bib19","first-page":"757","article-title":"Frontal fibrosing alopecia: an update on epidemiology and treatment","volume":"106","author":"Martinez-Perez","year":"2015","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib20","doi-asserted-by":"crossref","first-page":"e13379","DOI":"10.1111\/dth.13379","article-title":"5-Alpha reductase inhibitors in androgenetic alopecia: shifting paradigms, current concepts, comparative efficacy, and safety","volume":"33","author":"Dhurat","year":"2020","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/09546634.2019.1595507","article-title":"Finasteride and androgenic alopecia; from therapeutic options to medical implications","volume":"31","author":"Motofei","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib22","first-page":"637","article-title":"Effective treatment of female androgenic alopecia with dutasteride","volume":"4","author":"Olszewska","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14656566.2020.1721463","article-title":"A review of the treatment of male pattern hair loss","volume":"21","author":"York","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"10.1016\/j.jaad.2021.05.016_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jdv.14930","article-title":"5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update","volume":"32","author":"Murad","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaad.2019.03.079","article-title":"Medical therapy for frontal fibrosing alopecia: a review and clinical approach","volume":"81","author":"Ho","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib26","doi-asserted-by":"crossref","first-page":"e12656","DOI":"10.1111\/dth.12656","article-title":"Tofacitinib for the treatment of lichen planopilaris: a case series","volume":"31","author":"Yang","year":"2018","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1365-2133.2010.09965.x","article-title":"Frontal fibrosing alopecia: a clinical review of 36 patients","volume":"163","author":"Samrao","year":"2010","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000505439","article-title":"Hair loss in lichen planopilaris and frontal fibrosing alopecia: not always irreversible","volume":"6","author":"Batra","year":"2020","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cup.13112","article-title":"Lichen planopilaris and frontal fibrosing alopecia cannot be differentiated by histopathology","volume":"45","author":"G\u00e1lvez-Canseco","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jaad.2019.11.006","article-title":"Diffuse variants of scalp lichen planopilaris: clinical, trichoscopic, and histopathologic features of 40 patients","volume":"83","author":"Starace","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0974-7753.203179","article-title":"Comparative analysis of immunopathological features of lichen planopilaris and female patients with frontal fibrosing alopecia","volume":"8","author":"Cerqueira","year":"2016","journal-title":"Int J Trichology"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.4233","article-title":"Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche","volume":"231","author":"Harries","year":"2013","journal-title":"J Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2021.05.016_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/exd.13071","article-title":"Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis","volume":"25","author":"Tziotzios","year":"2016","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archderm.1994.01690060100013","article-title":"Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution","volume":"130","author":"Kossard","year":"1994","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.136.2.205","article-title":"Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern?","volume":"136","author":"Zinkernagel","year":"2000","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib36","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1038\/s41598-017-09207-z","article-title":"The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins","volume":"7","author":"Brunner","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaad.2020.04.138","article-title":"Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation","volume":"84","author":"Glickman","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.05.016_bib39","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/cea.12979","article-title":"Identification of unique proteomic signatures in allergic and non-allergic skin disease","volume":"47","author":"Wang","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjd.14445","article-title":"Frontal Fibrosing Alopecia Severity Index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia","volume":"175","author":"Holmes","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaad.2017.09.034","article-title":"Development and validation of the frontal fibrosing alopecia severity score","volume":"78","author":"Saceda-Corralo","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2013Part II","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2015.07.023","article-title":"Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis","volume":"242","author":"Lind","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib44","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2019.04.036","article-title":"The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease","volume":"81","author":"Brunner","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bjd.17932","article-title":"The Oral JAK\/SYK inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomised, double-blind, placebo-controlled study","volume":"181","author":"Bissonnette","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2018.08.024","article-title":"Atopic dermatitis in African American patients is TH2\/TH22-skewed with TH1\/TH17 attenuation","volume":"122","author":"Sanyal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2015.03.003","article-title":"RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications","volume":"135","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib50","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.07.013","article-title":"Oral Janus kinase\/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis","volume":"144","author":"Pavel","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib52","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaci.2020.04.055","article-title":"Phase 2 randomized, double-blind study of IL-17-targeting with secukinumab in atopic dermatitis","volume":"147","author":"Ungar","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.05.016_bib53","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"4","key":"10.1016\/j.jaad.2021.05.016_bib54","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2020.01.005","article-title":"Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients","volume":"145","author":"Glickman","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib55","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Suarez-Farinas","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13073-016-0384-y","article-title":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits","volume":"8","author":"Fang","year":"2016","journal-title":"Genome Med"},{"issue":"Database issue","key":"10.1016\/j.jaad.2021.05.016_bib58","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs","volume":"38","author":"Kanehisa","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/152791601750294344","article-title":"BioCarta","volume":"2","author":"Nishimura","year":"2001","journal-title":"Biotech Softw Internet Rep"},{"issue":"Database issue","key":"10.1016\/j.jaad.2021.05.016_bib60","doi-asserted-by":"crossref","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","article-title":"The reactome pathway knowledgebase","volume":"42","author":"Croft","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4352","article-title":"Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury","volume":"83","author":"Nakajima","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"10.1016\/j.jaad.2021.05.016_bib62","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-0560.2007.00892.x","article-title":"Involvement of granzyme B and granulysin in the cytotoxic response in lichen planus","volume":"35","author":"Ammar","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib63","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2006-10-051649","article-title":"Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program","volume":"110","author":"Fellows","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2020.05.048","article-title":"Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis","volume":"147","author":"He","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib66","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization","volume":"136","author":"Noda","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaci.2018.07.028","article-title":"Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab","volume":"143","author":"Brunner","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib68","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin","volume":"138","author":"Esaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2021.05.016_bib70","doi-asserted-by":"crossref","first-page":"597741","DOI":"10.3389\/fimmu.2020.597741","article-title":"RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17\/Th22, and JAK3-skewing","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jaad.2021.05.016_bib71","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bbamcr.2012.07.004","article-title":"Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc","volume":"1823","author":"Wang","year":"2012","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.jaad.2021.05.016_bib72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.rinim.2012.05.003","article-title":"Fas\/FasL and perforin\u2013granzyme pathways mediated T cell cytotoxic responses in infectious bursal disease virus infected chickens","volume":"2","author":"Rauf","year":"2012","journal-title":"Results Immunol"},{"issue":"21","key":"10.1016\/j.jaad.2021.05.016_bib73","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1111\/febs.12419","article-title":"Lymphotoxin \u03b1 induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor","volume":"280","author":"Etemadi","year":"2013","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib74","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jisp.2017.10.005","article-title":"Cytokine targeted therapeutics for alopecia areata: lessons from atopic dermatitis and other inflammatory skin diseases. Paper presented at: Journal of Investigative Dermatology Symposium Proceedings","volume":"19","author":"Malik","year":"2018","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"9","key":"10.1016\/j.jaad.2021.05.016_bib75","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib76","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.jaad.2021.05.016_bib79","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2443.2005.00902.x","article-title":"Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage","volume":"10","author":"Naitoh","year":"2005","journal-title":"Genes Cells"},{"issue":"20","key":"10.1016\/j.jaad.2021.05.016_bib80","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1074\/jbc.M707390200","article-title":"Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis","volume":"283","author":"Hanley","year":"2008","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib81","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1074\/jbc.M606262200","article-title":"Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation","volume":"282","author":"Stojadinovic","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib82","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.jid.5701149","article-title":"Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib83","doi-asserted-by":"crossref","first-page":"e0172955","DOI":"10.1371\/journal.pone.0172955","article-title":"Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology","volume":"12","author":"Jumper","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2021.05.016_bib84","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2021.05.016_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60582-9","article-title":"The Janus protein tyrosine kinase family and its role in cytokine signaling","volume":"60","author":"Ihle","year":"1995","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaad.2021.05.016_bib87","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fonc.2018.00287","article-title":"\u201cDo we know jack\u201d about JAK? A closer look at JAK\/STAT signaling pathway","volume":"8","author":"Bousoik","year":"2018","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2021.05.016_bib88","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/ced.14425","article-title":"Evaluation of serum cardiac troponin I and N-terminal pro-B-type natriuretic peptide levels in patients with alopecia areata","volume":"46","author":"El-Sayed Mahmoud Marie","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.05.016_bib90","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2340\/00015555-2964","article-title":"Alopecia areata is associated with increased expression of heart disease biomarker cardiac troponin I","volume":"98","author":"Wang","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib91","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jid.2017.08.040","article-title":"Reduction of inflammatory and cardiovascular proteins in the blood of patients with psoriasis: differential responses between tofacitinib and etanercept after 4 weeks of treatment","volume":"138","author":"Kim","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib92","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bjd.14219","article-title":"Abnormal regulation of fibronectin production by fibroblasts in psoriasis","volume":"174","author":"Guban","year":"2016","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.05.016_bib93","doi-asserted-by":"crossref","first-page":"150032","DOI":"10.1098\/rsob.150032","article-title":"Analysis of epithelial-mesenchymal transition markers in psoriatic epidermal keratinocytes","volume":"5","author":"Man","year":"2015","journal-title":"Open Biol"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2340\/00015555-2462","article-title":"Transforming growth factor beta gene signatures are spatially enriched in keloid tissue biopsies and ex\u00a0vivo-cultured keloid fibroblasts","volume":"97","author":"Taylor","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2021.05.016_bib95","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.12688\/f1000research.26728.1","article-title":"Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases","volume":"9","author":"Groover","year":"2020","journal-title":"F1000Res"},{"issue":"9","key":"10.1016\/j.jaad.2021.05.016_bib96","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s004030050239","article-title":"Hair cycle-dependent changes in the gene expression and protein content of transforming factor \u03b21 and \u03b23 in murine skin","volume":"289","author":"Welker","year":"1997","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib97","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/iwj.12034","article-title":"Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice","volume":"11","author":"Wu","year":"2014","journal-title":"Int Wound J"},{"issue":"1-2","key":"10.1016\/j.jaad.2021.05.016_bib98","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2005.09.008","article-title":"Smad3 is key to TGF-\u03b2-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis","volume":"17","author":"Roberts","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"issue":"30","key":"10.1016\/j.jaad.2021.05.016_bib99","doi-asserted-by":"crossref","first-page":"E4320","DOI":"10.1073\/pnas.1519197113","article-title":"Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-\u03b2\u2013slug signaling","volume":"113","author":"Cheng","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-001-0479-6","article-title":"Mechanisms of TGF-\u03b2-mediated apoptosis","volume":"307","author":"Schuster","year":"2002","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jdermsci.2010.11.015","article-title":"Epithelial\u2013mesenchymal transition in the skin","volume":"61","author":"Nakamura","year":"2011","journal-title":"J Dermatol Sci"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib102","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.molmed.2018.03.007","article-title":"Lichen planopilaris and frontal fibrosing alopecia as model epithelial stem cell diseases","volume":"24","author":"Harries","year":"2018","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib103","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1365-2133.2010.09682.x","article-title":"Expression of Snail1 in the fibrotic dermis of postmenopausal frontal fibrosing alopecia: possible involvement of an epithelial-mesenchymal transition and a review of the Japanese patients","volume":"162","author":"Nakamura","year":"2010","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.05.016_bib104","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.34500","article-title":"JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor \u03b2 in systemic sclerosis","volume":"64","author":"Dees","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jaad.2021.05.016_bib106","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jid.2019.12.019","article-title":"Jak inhibition prevents bleomycin-induced fibrosis in mice and is effective in patients with morphea","volume":"140","author":"Damsky","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib107","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijmm.2016.2692","article-title":"Targeted blockade of JAK\/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells","volume":"38","author":"Gu","year":"2016","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.jaad.2021.05.016_bib112","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jid.2019.11.027","article-title":"Molecular and cellular responses to the TYK2\/JAK1 inhibitor PF-06700841 reveal reduction of skin inflammation in plaque psoriasis","volume":"140","author":"Page","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2021.05.016_bib113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.31138\/mjr.31.1.137","article-title":"Under development JAK inhibitors for dermatologic diseases","volume":"31","author":"Sideris","year":"2020","journal-title":"Mediterr J Rheumatol"},{"issue":"18","key":"10.1016\/j.jaad.2021.05.016_bib114","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.3390\/ijms21186458","article-title":"Interleukin-36 cytokine\/receptor signaling: a new target for tissue fibrosis","volume":"21","author":"Melton","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2021.05.016_bib115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cytogfr.2020.06.006","article-title":"IL-36 in chronic inflammation and cancer","volume":"55","author":"Neurath","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaad.2021.05.016_bib116","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/5584_2020_488","article-title":"Interleukin-36: structure, signaling and function","volume":"21","author":"Zhou","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib117","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.smim.2013.11.003","article-title":"Biology of IL-36 cytokines and their role in disease","volume":"25","author":"Gresnigt","year":"2013","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib118","doi-asserted-by":"crossref","first-page":"e144336","DOI":"10.1172\/JCI144336","article-title":"IL-36 in chronic inflammation and fibrosis\u2014Bridging the gap?","volume":"131","author":"Elias","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib119","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thoraxjnl-2012-202003","article-title":"IL-25 drives remodelling in allergic airways disease induced by house dust mite","volume":"68","author":"Gregory","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jaad.2021.05.016_bib121","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ACI.0000000000000133","article-title":"Recent advances in epithelium-derived cytokines (IL-33, IL-25, and TSLP) and allergic inflammation","volume":"15","author":"Divekar","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.05.016_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.12.628","article-title":"IL-25 (IL-17E) in epithelial immunology and pathophysiology","author":"Borowczyk","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.jaad.2021.05.016_bib123","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/intimm\/dxz020","article-title":"Regulatory T cells in inflammatory skin disease: from mice to humans","volume":"31","author":"Kalekar","year":"2019","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.jaad.2021.05.016_bib124","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.05.016_bib125","doi-asserted-by":"crossref","first-page":"e0210308","DOI":"10.1371\/journal.pone.0210308","article-title":"Alopecia areata patients show deficiency of FOXP3+ CD39+ T regulatory cells and clonotypic restriction of Treg TCR\u03b2-chain, which highlights the immunopathological aspect of the disease","volume":"14","author":"Hamed","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaad.2021.05.016_bib126","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib127","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib128","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1172\/JCI72932","article-title":"Memory regulatory T cells reside in human skin","volume":"124","author":"Sanchez Rodriguez","year":"2014","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/exd.13664","article-title":"A proposed mechanism for central centrifugal cicatricial alopecia","volume":"29","author":"Subash","year":"2020","journal-title":"Exp Dermatol"},{"issue":"47","key":"10.1016\/j.jaad.2021.05.016_bib130","doi-asserted-by":"crossref","first-page":"eaaz9631","DOI":"10.1126\/sciimmunol.aaz9631","article-title":"Regulatory T cells in skin injury: at the crossroads of tolerance and tissue repair","volume":"5","author":"Boothby","year":"2020","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","article-title":"TGF-\u03b2-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing","volume":"35","author":"Schiller","year":"2004","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.jaad.2021.05.016_bib132","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2021.05.016_bib133","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front Pharmacol"},{"issue":"39","key":"10.1016\/j.jaad.2021.05.016_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw2910","article-title":"Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses","volume":"4","author":"Kalekar","year":"2019","journal-title":"Sci Immunol"},{"issue":"8","key":"10.1016\/j.jaad.2021.05.016_bib135","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14712598.2016.1188076","article-title":"A novel therapeutic paradigm for patients with extensive alopecia areata","volume":"16","author":"Renert-Yuval","year":"2016","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"10.1016\/j.jaad.2021.05.016_bib136","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archdermatol.2009.264","article-title":"Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study","volume":"145","author":"Strober","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.05.016_bib137","first-page":"431","article-title":"Successful treatment of alopecia universalis with alefacept: a case report and review of the literature","volume":"81","author":"Bui","year":"2008","journal-title":"Cutis"},{"issue":"12","key":"10.1016\/j.jaad.2021.05.016_bib138","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.141.12.1513","article-title":"Alefacept for alopecia areata","volume":"141","author":"Heffernan","year":"2005","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.05.016_bib139","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaad.2020.09.091","article-title":"An open-label study evaluating the efficacy of abatacept in alopecia areata","volume":"84","author":"Mackay-Wiggan","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.05.016_bib140","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","article-title":"The changing landscape of alopecia areata: the therapeutic paradigm","volume":"34","author":"Renert-Yuval","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2021.05.016_bib141","first-page":"137","article-title":"320 An open label clinical trial of abatacept (CTLA4-Ig) for alopecia areata","volume":"320","author":"Sansaricq","year":"2017","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221009993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221009993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:00:59Z","timestamp":1759273259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221009993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0190962221009993"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.05.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}